Inge M.C.M. de Kok

The challenges of organising cervical screening programmes in the 15 old member states of the European Union

Marc Arbyn, Matejka Rebolj, Inge M.C.M. de Kok et al. · European Journal of Cancer · 2009 · 170 citations

Medicine, Health Policy, Preventive Medicine +13

Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study

Clare A. Aitken, Heleen M.E. van Agt, Albert G. Siebers et al. · BMC Medicine · 2019 · 140 citations · Full text

Medicine, Pathology, Preventive Medicine +17

The potential of breast cancer screening in Europe

N. Zielonke, Lindy M. Kregting, Eveline A.M. Heijnsdijk et al. · International Journal of Cancer · 2020 · 123 citations · Full text

Medicine, Oncology, Preventive Medicine +14

Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study

Federica Inturrisi, Clare A. Aitken, Willem J. G. Melchers et al. · The Lancet Regional Health - Europe · 2021 · 101 citations · Full text

Medicine, Pathology, Preventive Medicine +17

Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model

Inge M.C.M. de Kok, Joost van Rosmalen, Joakim Dillner et al. · BMJ · 2012 · 98 citations · Full text

Medicine, Oncology, Preventive Medicine +17